Age-specific incidence trends and future burden of hepatitis E in China: a nationwide 16-year study with vaccination scenarios
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background: Reported hepatitis E incidence has increased in China, but the relative contributions of age-specific rates, population ageing and temperature remain incompletely quantified. We assessed these contributions and explored the potential direct impact of vaccination scenarios. Methods: We analysed 388,867 cases reported in 31 mainland provincial-level divisions during 2005–2020 by age band (0–19, 20–59, ≥ 60 years). Trend, decomposition and temperature analyses ended in 2019; 2020 was used for description and sensitivity analyses. Kitagawa decomposition separated age-structure and age-specific-rate contributions. Province-specific distributed-lag non-linear models were pooled by multivariate meta-analysis. Projections combined the 2015–2019 baseline, United Nations population scenarios and temperature-derived climate multipliers. Fixed rates were compared with log-linear continuation using 2013–2019 and 2005–2019 windows. Vaccination scenarios estimated direct protection against reported clinical disease. Results: Between 2005 and 2019, crude incidence rose from 1.21 to 2.01 per 100,000; 78.9% of the increase was attributed to age-specific rates and 21.1% to age structure. At 27.37°C versus 14.178°C, the pooled relative risk among adults aged ≥ 60 years was 1.36 (95% CI 1.03–1.82), with I²=0%; younger-band associations were non-significant. With age-specific rates fixed, annual cases in the 2050s were 34,365 under SSP2-4.5 and 34,667 under SSP5-8.5, respectively 22.0% and 23.1% above baseline; older-adult cases approximately doubled. Recent-trend scenarios ranged from 27,204 to 31,657 under SSP2-4.5, reflecting a fitted annual decline of 1.70% in reported incidence among adults aged ≥ 60 years during 2013–2019; long-term trend scenarios were substantially higher. Under fixed-rate SSP2-4.5 in the 2050s, 60% effective full-course coverage among adults aged ≥ 60 years could potentially avert 10,290 reported cases annually, requiring 26,940 full courses per case averted. Conclusions: Historical increases were driven mainly by age-specific rates, whereas ageing dominates fixed-rate projections. Future burden depends on trend window and damping. Older adults combine high reported incidence with a modest warm-tail association whose magnitude was sensitive to inclusion of 2020. Vaccination estimates illustrate targeting efficiency, not cost-effectiveness or a recommendation for routine older-adult immunisation.
Source: Research Square
Authors: Fei Wang(Conceptualization, Data curation, Formal analysis, Visualization, Writing – original draft), Yajuan He(Conceptualization, Data curation, Methodology, Validation, Writing – original draft), Yuanyuan Duan(Investigation, Resources, Validation), Mi Ke(Validation, Writing – review & editing), Yuxin Liu(Data curation, Methodology, Validation), Tianyan Chen(Supervision, Writing – review & editing), Zhen Tian(Conceptualization, Funding acquisition, Project administration, Supervision, Writing – review & editing)
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7236614632
